I see Qantas as a relatively low risk / high reward vaccine...

I see Qantas as a relatively low risk / high reward vaccine play. Very well managed company, weak competition, and Lonsec currently have them valued at $4.50. They are likely to go $5 plus comfortably if and when any of the stage 3 trials are shown to be effective. I think the high institutional demand for the $3.65 SPP underpins the value a little so I see these prices as good buying for a 6 to 12 month time frame.

Obviously no-one knows if and when we'll get a vaccine but when billions of dollars and a $hit-tonne of political Will (including a desperate U.S. president trying to get re-elected) are thrown at the problem, I like our chances.